Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03604107 · ClinicalTrials.gov registry record
Predictive Value of Embryonic Testing
A clinical trial, sponsored by Reproductive Medicine Associates of New Jersey.
- Completed
- Registry status
- 237
- Enrollment target
NCT03604107 is a clinical trial that has completed, run by Reproductive Medicine Associates of New Jersey. The registered enrollment target is 237 participants.
The verdict
NCT03604107 has completed, sponsored by Reproductive Medicine Associates of New Jersey.
- COMPLETED
- Registry status
- 237 participants
- Enrollment target
Study Summary
The primary objective of this study is to determine the predictive value of preimplantation genetic screening (PGS) as a marker of embryonic competence. Secondary objectives are to define the related or independent predictive values of other proposed markers of embryonic and maternal reproductive competence in assisted reproductive technology (ART) cycles.
Interventions
- GENETIC Preimplantation Genetic Testing-Aneuploidy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 237 participants |
| Start Date | 2018-07-30 |
| Est. Completion | 2020-12-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03604107
The ClinicalTrials.gov registry entry for NCT03604107 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 237 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Reproductive Medicine Associates of New Jersey, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Preimplantation Genetic Testing-Aneuploidy is the first listed.
NCT03604107 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03604107 about?
NCT03604107 is a clinical study titled "Predictive Value of Embryonic Testing". The primary objective of this study is to determine the predictive value of preimplantation genetic screening (PGS) as a marker of embryonic competence. Secondary objectives are to define the related or independent predictive values of other proposed markers of embryonic and maternal reproductive co...
What is the current status of trial NCT03604107?
This trial is currently completed. The enrollment target is 237 participants. The study started on 2018-07-30. Estimated completion is 2020-12-01.
What interventions are being tested in trial NCT03604107?
The interventions under investigation include: Preimplantation Genetic Testing-Aneuploidy (GENETIC).
Who is sponsoring clinical trial NCT03604107?
This trial is sponsored by Reproductive Medicine Associates of New Jersey, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.